IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Adial Pharmaceuticals Inc

Q4 2024 vs Q1 2025

Comparing institutional holders between quarters

Quarters

Q1 2025Q4 2024Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
1620 Investment Advisors, Inc.
UNCHANGED
Shares3,600 from 3,600
Change0 (0%)
Value$2.3K (-$1.4K)
Filed 2025-05-14
Status
1620 Investment Advisors, Inc.
UNCHANGED3,6003,60000%$3.6K$2.3K-$1.4K2025-05-14
Showing 1 of 1 institutions